BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27223086)

  • 1. Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling.
    Liu Y; Li F; Gao F; Xing L; Qin P; Liang X; Zhang J; Qiao X; Lin L; Zhao Q; Du L
    Oncotarget; 2016 Jun; 7(26):40148-40159. PubMed ID: 27223086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periostin Limits Tumor Response to VEGFA Inhibition.
    Keklikoglou I; Kadioglu E; Bissinger S; Langlois B; Bellotti A; Orend G; Ries CH; De Palma M
    Cell Rep; 2018 Mar; 22(10):2530-2540. PubMed ID: 29514082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling.
    Sun Y; Wu C; Ma J; Yang Y; Man X; Wu H; Li S
    Exp Cell Res; 2016 Oct; 347(2):274-82. PubMed ID: 27426724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
    Cao F; Wang S; Wang H; Tang W
    Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
    Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
    Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin‑1.
    Zhang Z; Nie F; Chen X; Qin Z; Kang C; Chen B; Ma J; Pan B; Ma Y
    Mol Med Rep; 2015 Feb; 11(2):857-64. PubMed ID: 25369801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dab2 is pivotal for endothelial cell migration by mediating VEGF expression in cancer cells.
    Cheong SM; Choi H; Hong BS; Gho YS; Han JK
    Exp Cell Res; 2012 Mar; 318(5):550-7. PubMed ID: 22265793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PERIOSTIN regulates MMP-2 expression via the αvβ3 integrin/ERK pathway in human periodontal ligament cells.
    Watanabe T; Yasue A; Fujihara S; Tanaka E
    Arch Oral Biol; 2012 Jan; 57(1):52-9. PubMed ID: 21885032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
    Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
    J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
    J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer.
    Li X; Wang X; Li Z; Zhang Z; Zhang Y
    Cancer Med; 2019 Sep; 8(11):5327-5340. PubMed ID: 31348616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype.
    Wang H; Wang Y; Jiang C
    Int J Oncol; 2013 May; 42(5):1716-24. PubMed ID: 23467707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
    Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
    Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.